Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET

other OA: bronze public-domain-us
AI-generated summary by claude@2026-06, 2026-06-08

This study found that the homozygous Ser/Ser genotype of the FSHR gene at position 680 was associated with a reduced ovarian response and lower pregnancy rates in Korean women undergoing IVF-ET.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This study was performed to investigate the association between FSH receptor (FSHR) gene polymorphism at position 680 and the outcomes of controlled ovarian hyperstimulation (COH) for in vitro fertilization and embryo transfer (IVF-ET) in Korean women. Two hundred and sixty-three patients under 40 years of age who underwent IVF-ET procedures were included in this study. Patients with polycystic ovary syndrome, endometriosis, or a previous history of ovarian surgery were excluded. Following extraction of genomic DNA, the FSHR polymorphism at position 680 was determined by polymerase chain reaction and restriction fragment length polymorphism analysis. The FSHR genotype distribution was 41.8% for Asn/Asn, 45.6% for Asn/Ser, and 12.5% for Ser/Ser FSHR genotype groups. Although there was no difference among the three genotype groups in terms of the age and infertility diagnosis of study subjects, the basal levels of FSH (day 3) were significantly different [5.7 +/- 0.3 IU/l (mean+/-SEM), 6.0 +/- 0.3 IU/l, and 8.2 +/- 0.9 IU/l for Asn/Asn, Asn/Ser, and Ser/Ser groups, respectively. The Ser/Ser group tended to require a higher dose of gonadotropins for COH, and tended to show lower serum estradiol levels at the time of hCG administration than the other two groups, though these differences did not reach statistical significance. The numbers of oocytes retrieved tended to be different for the three groups (9.6 +/- 0.6, 10.2 +/- 0.6, and 7.9 +/- 0.8 for Asn/Asn, Asn/Ser, and Ser/Ser groups, respectively). Clinical pregnancy rate was significantly higher in Asn/Asn, compared to the others (45.7 vs. 30.5%, P=0.013). The homozygous Ser/Ser genotype of FSHR polymorphism at position 680 may be associated with a reduced ovarian response to COH for IVF-ET, while Asn/Asn genotypes showed a higher pregnancy rate.
Full text 6,233 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Abstract

This study was performed to investigate the association between FSH receptor (FSHR) gene polymorphism at position 680 and the outcomes of controlled ovarian hyperstimulation (COH) for in vitro fertilization and embryo transfer (IVF-ET) in Korean women. Two hundred and sixty-three patients under 40 years of age who underwent IVF-ET procedures were included in this study. Patients with polycystic ovary syndrome, endometriosis, or a previous history of ovarian surgery were excluded. Following extraction of genomic DNA, the FSHR polymorphism at position 680 was determined by polymerase chain reaction and restriction fragment length polymorphism analysis. The FSHR genotype distribution was 41.8% for Asn/Asn, 45.6% for Asn/Ser, and 12.5% for Ser/Ser FSHR genotype groups. Although there was no difference among the three genotype groups in terms of the age and infertility diagnosis of study subjects, the basal levels of FSH (day 3) were significantly different [5.7 ± 0.3 IU/l (mean±SEM), 6.0 ± 0.3 IU/l, and 8.2 ± 0.9 IU/l for Asn/Asn, Asn/Ser, and Ser/Ser groups, respectively. The Ser/Ser group tended to require a higher dose of gonadotropins for COH, and tended to show lower serum estradiol levels at the time of hCG administration than the other two groups, though these differences did not reach statistical significance. The numbers of oocytes retrieved tended to be different for the three groups (9.6 ± 0.6, 10.2 ± 0.6, and 7.9 ± 0.8 for Asn/Asn, Asn/Ser, and Ser/Ser groups, respectively). Clinical pregnancy rate was significantly higher in Asn/Asn, compared to the others (45.7 vs. 30.5%, P=0.013). The homozygous Ser/Ser genotype of FSHR polymorphism at position 680 may be associated with a reduced ovarian response to COH for IVF-ET, while Asn/Asn genotypes showed a higher pregnancy rate. Similar content being viewed by others Log in or create a free account to read this content Gain free access to this article, as well as selected content from this journal and more on nature.com or

References

Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, Kaskikari R, Sankila EM, Lehvaslaiho H, Engel AR et al (1995) Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82:959–968 Balasch J, Creus M, Fabregues F, Carmona F, Casamitjana R, Ascaso C, Vanrell JA (1996) Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Am J Obstet Gynecol 175:1226–1230 de Castro F, Ruiz R, Montoro L, Perez-Hernandez D, Sanchez-Casas Padilla E, Real LM, Ruiz A (2003) Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil Steril 80:571–576 Davis D, Liu X, Segaloff DL (1995) Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone receptor and assessment of their role in FSH receptor function. Mol Endocrinol 9:159–170 Fauser BC (1996) Interference of follicle-stimulation hormone regulation of human ovarian function. Mol Hum Reprod 2:327–334 Fauser BC, van Heusden AM (1997) Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 18:71–106 Kligman I, Rosenwaks Z (2001) Differentiating clinical profiles: prediction good responders, poor responders, and hyperresponders. Fertil Steril 76:1185–1190 Mayorga MP, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M (2000) Ovarian response to follicle-stimulating hormone stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 85:3365–3369 Simoni M, Gromoll J, Nieschalg E (1997) The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 18:739–773 Spearow JL, Barkley M (1999) Genetic control of hormone-induced ovulation in mice. Biol Reprod 61:851–856 Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ, Fujimoto S (2002) Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod 8:893–839 Tinkanen H, Blauer M, Laippala P, Tuohimaa P, Kujansuu E (1999) Prognostic factors in controlled ovarian hyperstimulation. Fertil Steril 72:932–936 Ulloa-Aguirre A, Midgley AR Jr, Beitins IZ, Padmanabhan V (1995) Follicle-stimulating isohormones: characterization and physiological relevance. Endocr Rev 16:765–787 Zambrano E, Zarinan T, Olivares A, Barrios-de-Tomasi J, Ulloa-Aguirre A (1999) Receptor binding activity and in vitro biological activity of the human FSH charge isoforms as disclosed by heterologous and homologous assay systems: implication for the structure-function relationship of the FSH variants. Endocrine 10:113–121

Acknowledgements

This study was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (01-PJ10-PG6-01GN13-0002). Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Jun, J.K., Yoon, J.S., Ku, SY. et al. Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J Hum Genet 51, 665–670 (2006). https://doi.org/10.1007/s10038-006-0005-5 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s10038-006-0005-5

Keywords

This article is cited by - An overview of FSH-FSHR biology and explaining the existing conundrums Journal of Ovarian Research (2021) - Could polymorphisms of some hormonal receptor genes, involved in folliculogenesis help in predicting patient response to controlled ovarian stimulation? Journal of Assisted Reproduction and Genetics (2019) - The carriers of the A/G-G/G allelic combination of the c.2039 A>G and c.-29 G>A FSH receptor polymorphisms retrieve the highest number of oocytes in IVF/ICSI cycles Journal of Assisted Reproduction and Genetics (2017) - Heat stress impairs mice granulosa cell function by diminishing steroids production and inducing apoptosis Molecular and Cellular Biochemistry (2016) - FSH-Rezeptor-Polymorphismen und kontrollierte ovarielle Stimulation Gynäkologische Endokrinologie (2015)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

MeSH descriptors

Embryo Transfer Fertilization in Vitro Ovarian Hyperstimulation Syndrome Ovary Polymorphism, Genetic Receptors, FSH Adult Age Distribution Female Fertilization in Vitro Genotype Humans Infertility, Female Ovarian Hyperstimulation Syndrome Ovary Polymorphism, Genetic Receptors, FSH Treatment Outcome

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
pubmed
last seen: 2026-05-13T22:15:12.369988+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine